IZOTROPIC CORPORATION - IZO CSE / IZOZF OTC / FRA 1R3
Izotropic Breast Imaging System - Presentation
Investor Relations 1- 833-496-2677 Call For Updates
New Listings - US OTC / Frankfurt Stock Exchange
Accurate Revolutionary Breast Imaging - The Future Is Now
| Izotropic Corp,
a medical device company with new revolutionary technology
focused on detecting and screening for breast cancer. Breast
cancer detection is an $8 billion industry. Over 522,000 women die each year from the disease with 1.7 million cases detected. IZO's technology is supported by 2 patents and 5 pending patents. Since coming public the stock has traded as high as $0.50 cents and currently forming a solid base at the $0.30 cent level. We urge all serious investors to place these shares on their BUY LIST Dr John Boone Founder - Video Interview Dr Boone Podcast Mammography vs Breast CT Dr Boone Podcast Tomosynthesis vs Breast CT WEBSITE - ABOUT - MANAGEMENT - BREAST CT - IMAGING - POWERPOINT |
Izotropic Corporation Establishes New U.S. Operating Company and Launches New WebsiteVancouver BC - TheNewswire - July 9, 2019 -- Izotropic Corporation (CNSX:IZO.CN) (OTC:IZOZF) announces that it has established Izotropic Imaging Corp., a wholly owned subsidiary based in the State of Nevada. Izotropic Imaging Corp will be the Company's operating entity for all business operations and initiatives planned in the U.S.A. New Website - in addition the company has just completed a rebranding initiative and announces the launch of its new website: www.izocorp.com On
behalf of the Board of Directors 1- 833-496-2677 Call For Updates About Izotropic Corp. The company is engaged in the development and commercialization of next-generation 3-D breast CT imaging technology for early diagnosis of breast cancer, that improves patient comfort, provides a true 360-degree-view acquisition and delivers high diagnostic accuracy.
|